世界のバイオ医薬品受託製造（BCMO）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Biopharmaceutical Contract Manufacturing Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0828
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、90ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、バイオ医薬品受託製造（BCMO）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（成長因子、インターフェロン、モノクローナル抗体、組換えホルモン、ワクチン、インスリン、その他）、用途別市場規模（自己免疫疾患、腫瘍、代謝性疾患、眼科、心血管疾患、感染症、神経、呼吸器疾患、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・バイオ医薬品受託製造（BCMO）の市場動向
・企業の競争状況、市場シェア
・バイオ医薬品受託製造（BCMO）の種類別市場規模（成長因子、インターフェロン、モノクローナル抗体、組換えホルモン、ワクチン、インスリン、その他）
・バイオ医薬品受託製造（BCMO）の用途別市場規模（自己免疫疾患、腫瘍、代謝性疾患、眼科、心血管疾患、感染症、神経、呼吸器疾患、その他）
・バイオ医薬品受託製造（BCMO）の北米市場規模2016-2027（アメリカ、カナダ）
・バイオ医薬品受託製造（BCMO）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・バイオ医薬品受託製造（BCMO）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・バイオ医薬品受託製造（BCMO）の中南米市場規模2016-2027（メキシコ、ブラジル）
・バイオ医薬品受託製造（BCMO）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Lonza Group、Baxter Biopharma Solutions、Samsung、Fujifilm Diosynth Biotechnologies、Boehringer Ingelheim、Patheon、Rentschler Biotechnologie、Biomeva、Probiogen、Cytovance Biologics、KBI Biopharma、WuXi Biologics、Abzena）
・結論

Market Analysis and Insights: Global Biopharmaceutical Contract Manufacturing Market
The global Biopharmaceutical Contract Manufacturing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biopharmaceutical Contract Manufacturing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biopharmaceutical Contract Manufacturing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biopharmaceutical Contract Manufacturing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biopharmaceutical Contract Manufacturing market.

Global Biopharmaceutical Contract Manufacturing Scope and Market Size
Biopharmaceutical Contract Manufacturing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical Contract Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Growth Factors
Interferons
Monoclonal Antibodies
Recombinant Hormones
Vaccines
Insulin
Others

Segment by Application
Autoimmune Diseases
Oncology
Metabolic Diseases
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Neurology
Respiratory Disorders
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Lonza Group
Baxter Biopharma Solutions
Samsung
Fujifilm Diosynth Biotechnologies
Boehringer Ingelheim
Patheon
Rentschler Biotechnologie
Biomeva
Probiogen
Fujifilm Diosynth Biotechnologies
Boehringer Ingelheim

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Growth Factors
1.2.3 Interferons
1.2.4 Monoclonal Antibodies
1.2.5 Recombinant Hormones
1.2.6 Vaccines
1.2.7 Insulin
1.2.8 Others
1.3 Market by Application
1.3.1 Global Biopharmaceutical Contract Manufacturing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Autoimmune Diseases
1.3.3 Oncology
1.3.4 Metabolic Diseases
1.3.5 Ophthalmology
1.3.6 Cardiovascular Diseases
1.3.7 Infectious Diseases
1.3.8 Neurology
1.3.9 Respiratory Disorders
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Biopharmaceutical Contract Manufacturing Market Perspective (2016-2027)
2.2 Biopharmaceutical Contract Manufacturing Growth Trends by Regions
2.2.1 Biopharmaceutical Contract Manufacturing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biopharmaceutical Contract Manufacturing Historic Market Share by Regions (2016-2021)
2.2.3 Biopharmaceutical Contract Manufacturing Forecasted Market Size by Regions (2022-2027)
2.3 Biopharmaceutical Contract Manufacturing Industry Dynamic
2.3.1 Biopharmaceutical Contract Manufacturing Market Trends
2.3.2 Biopharmaceutical Contract Manufacturing Market Drivers
2.3.3 Biopharmaceutical Contract Manufacturing Market Challenges
2.3.4 Biopharmaceutical Contract Manufacturing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical Contract Manufacturing Players by Revenue
3.1.1 Global Top Biopharmaceutical Contract Manufacturing Players by Revenue (2016-2021)
3.1.2 Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Players (2016-2021)
3.2 Global Biopharmaceutical Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical Contract Manufacturing Revenue
3.4 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio
3.4.1 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Contract Manufacturing Revenue in 2020
3.5 Biopharmaceutical Contract Manufacturing Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical Contract Manufacturing Product Solution and Service
3.7 Date of Enter into Biopharmaceutical Contract Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Biopharmaceutical Contract Manufacturing Breakdown Data by Type
4.1 Global Biopharmaceutical Contract Manufacturing Historic Market Size by Type (2016-2021)
4.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Type (2022-2027)

5 Biopharmaceutical Contract Manufacturing Breakdown Data by Application
5.1 Global Biopharmaceutical Contract Manufacturing Historic Market Size by Application (2016-2021)
5.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Biopharmaceutical Contract Manufacturing Market Size (2016-2027)
6.2 North America Biopharmaceutical Contract Manufacturing Market Size by Type
6.2.1 North America Biopharmaceutical Contract Manufacturing Market Size by Type (2016-2021)
6.2.2 North America Biopharmaceutical Contract Manufacturing Market Size by Type (2022-2027)
6.2.3 North America Biopharmaceutical Contract Manufacturing Market Size by Type (2016-2027)
6.3 North America Biopharmaceutical Contract Manufacturing Market Size by Application
6.3.1 North America Biopharmaceutical Contract Manufacturing Market Size by Application (2016-2021)
6.3.2 North America Biopharmaceutical Contract Manufacturing Market Size by Application (2022-2027)
6.3.3 North America Biopharmaceutical Contract Manufacturing Market Size by Application (2016-2027)
6.4 North America Biopharmaceutical Contract Manufacturing Market Size by Country
6.4.1 North America Biopharmaceutical Contract Manufacturing Market Size by Country (2016-2021)
6.4.2 North America Biopharmaceutical Contract Manufacturing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Biopharmaceutical Contract Manufacturing Market Size (2016-2027)
7.2 Europe Biopharmaceutical Contract Manufacturing Market Size by Type
7.2.1 Europe Biopharmaceutical Contract Manufacturing Market Size by Type (2016-2021)
7.2.2 Europe Biopharmaceutical Contract Manufacturing Market Size by Type (2022-2027)
7.2.3 Europe Biopharmaceutical Contract Manufacturing Market Size by Type (2016-2027)
7.3 Europe Biopharmaceutical Contract Manufacturing Market Size by Application
7.3.1 Europe Biopharmaceutical Contract Manufacturing Market Size by Application (2016-2021)
7.3.2 Europe Biopharmaceutical Contract Manufacturing Market Size by Application (2022-2027)
7.3.3 Europe Biopharmaceutical Contract Manufacturing Market Size by Application (2016-2027)
7.4 Europe Biopharmaceutical Contract Manufacturing Market Size by Country
7.4.1 Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2016-2021)
7.4.2 Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size (2016-2027)
8.2 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Type
8.2.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Type (2016-2027)
8.3 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Application
8.3.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Application (2016-2027)
8.4 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region
8.4.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Biopharmaceutical Contract Manufacturing Market Size (2016-2027)
9.2 Latin America Biopharmaceutical Contract Manufacturing Market Size by Type
9.2.1 Latin America Biopharmaceutical Contract Manufacturing Market Size by Type (2016-2021)
9.2.2 Latin America Biopharmaceutical Contract Manufacturing Market Size by Type (2022-2027)
9.2.3 Latin America Biopharmaceutical Contract Manufacturing Market Size by Type (2016-2027)
9.3 Latin America Biopharmaceutical Contract Manufacturing Market Size by Application
9.3.1 Latin America Biopharmaceutical Contract Manufacturing Market Size by Application (2016-2021)
9.3.2 Latin America Biopharmaceutical Contract Manufacturing Market Size by Application (2022-2027)
9.3.3 Latin America Biopharmaceutical Contract Manufacturing Market Size by Application (2016-2027)
9.4 Latin America Biopharmaceutical Contract Manufacturing Market Size by Country
9.4.1 Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2016-2021)
9.4.2 Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size (2016-2027)
10.2 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Type
10.2.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Type (2016-2027)
10.3 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Application
10.3.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Application (2016-2027)
10.4 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country
10.4.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Lonza Group
11.1.1 Lonza Group Company Details
11.1.2 Lonza Group Business Overview
11.1.3 Lonza Group Biopharmaceutical Contract Manufacturing Introduction
11.1.4 Lonza Group Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021)
11.1.5 Lonza Group Recent Development
11.2 Baxter Biopharma Solutions
11.2.1 Baxter Biopharma Solutions Company Details
11.2.2 Baxter Biopharma Solutions Business Overview
11.2.3 Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Introduction
11.2.4 Baxter Biopharma Solutions Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021)
11.2.5 Baxter Biopharma Solutions Recent Development
11.3 Samsung
11.3.1 Samsung Company Details
11.3.2 Samsung Business Overview
11.3.3 Samsung Biopharmaceutical Contract Manufacturing Introduction
11.3.4 Samsung Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021)
11.3.5 Samsung Recent Development
11.4 Fujifilm Diosynth Biotechnologies
11.4.1 Fujifilm Diosynth Biotechnologies Company Details
11.4.2 Fujifilm Diosynth Biotechnologies Business Overview
11.4.3 Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Introduction
11.4.4 Fujifilm Diosynth Biotechnologies Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021)
11.4.5 Fujifilm Diosynth Biotechnologies Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Introduction
11.5.4 Boehringer Ingelheim Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Patheon
11.6.1 Patheon Company Details
11.6.2 Patheon Business Overview
11.6.3 Patheon Biopharmaceutical Contract Manufacturing Introduction
11.6.4 Patheon Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021)
11.6.5 Patheon Recent Development
11.7 Rentschler Biotechnologie
11.7.1 Rentschler Biotechnologie Company Details
11.7.2 Rentschler Biotechnologie Business Overview
11.7.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Introduction
11.7.4 Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021)
11.7.5 Rentschler Biotechnologie Recent Development
11.8 Biomeva
11.8.1 Biomeva Company Details
11.8.2 Biomeva Business Overview
11.8.3 Biomeva Biopharmaceutical Contract Manufacturing Introduction
11.8.4 Biomeva Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021)
11.8.5 Biomeva Recent Development
11.9 Probiogen
11.9.1 Probiogen Company Details
11.9.2 Probiogen Business Overview
11.9.3 Probiogen Biopharmaceutical Contract Manufacturing Introduction
11.9.4 Probiogen Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021)
11.9.5 Probiogen Recent Development
11.10 Cytovance Biologics
11.10.1 Cytovance Biologics Company Details
11.10.2 Cytovance Biologics Business Overview
11.10.3 Cytovance Biologics Biopharmaceutical Contract Manufacturing Introduction
11.10.4 Cytovance Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021)
11.10.5 Cytovance Biologics Recent Development
11.11 KBI Biopharma
11.11.1 KBI Biopharma Company Details
11.11.2 KBI Biopharma Business Overview
11.11.3 KBI Biopharma Biopharmaceutical Contract Manufacturing Introduction
11.11.4 KBI Biopharma Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021)
11.11.5 KBI Biopharma Recent Development
11.12 WuXi Biologics
11.12.1 WuXi Biologics Company Details
11.12.2 WuXi Biologics Business Overview
11.12.3 WuXi Biologics Biopharmaceutical Contract Manufacturing Introduction
11.12.4 WuXi Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021)
11.12.5 WuXi Biologics Recent Development
11.13 Abzena
11.13.1 Abzena Company Details
11.13.2 Abzena Business Overview
11.13.3 Abzena Biopharmaceutical Contract Manufacturing Introduction
11.13.4 Abzena Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021)
11.13.5 Abzena Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Growth Factors
Table 3. Key Players of Interferons
Table 4. Key Players of Monoclonal Antibodies
Table 5. Key Players of Recombinant Hormones
Table 6. Key Players of Vaccines
Table 7. Key Players of Insulin
Table 8. Key Players of Others
Table 9. Global Biopharmaceutical Contract Manufacturing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Biopharmaceutical Contract Manufacturing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Biopharmaceutical Contract Manufacturing Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Biopharmaceutical Contract Manufacturing Market Share by Regions (2016-2021)
Table 13. Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Biopharmaceutical Contract Manufacturing Market Share by Regions (2022-2027)
Table 15. Biopharmaceutical Contract Manufacturing Market Trends
Table 16. Biopharmaceutical Contract Manufacturing Market Drivers
Table 17. Biopharmaceutical Contract Manufacturing Market Challenges
Table 18. Biopharmaceutical Contract Manufacturing Market Restraints
Table 19. Global Biopharmaceutical Contract Manufacturing Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Biopharmaceutical Contract Manufacturing Market Share by Players (2016-2021)
Table 21. Global Top Biopharmaceutical Contract Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical Contract Manufacturing as of 2020)
Table 22. Ranking of Global Top Biopharmaceutical Contract Manufacturing Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Biopharmaceutical Contract Manufacturing Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Biopharmaceutical Contract Manufacturing Product Solution and Service
Table 26. Date of Enter into Biopharmaceutical Contract Manufacturing Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Biopharmaceutical Contract Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Type (2016-2021)
Table 30. Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Biopharmaceutical Contract Manufacturing Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Application (2016-2021)
Table 34. Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Biopharmaceutical Contract Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Biopharmaceutical Contract Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Biopharmaceutical Contract Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Biopharmaceutical Contract Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Biopharmaceutical Contract Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Biopharmaceutical Contract Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Biopharmaceutical Contract Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Biopharmaceutical Contract Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Biopharmaceutical Contract Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Biopharmaceutical Contract Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Biopharmaceutical Contract Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Biopharmaceutical Contract Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Biopharmaceutical Contract Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Biopharmaceutical Contract Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 66. Lonza Group Company Details
Table 67. Lonza Group Business Overview
Table 68. Lonza Group Biopharmaceutical Contract Manufacturing Product
Table 69. Lonza Group Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021) & (US$ Million)
Table 70. Lonza Group Recent Development
Table 71. Baxter Biopharma Solutions Company Details
Table 72. Baxter Biopharma Solutions Business Overview
Table 73. Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Product
Table 74. Baxter Biopharma Solutions Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021) & (US$ Million)
Table 75. Baxter Biopharma Solutions Recent Development
Table 76. Samsung Company Details
Table 77. Samsung Business Overview
Table 78. Samsung Biopharmaceutical Contract Manufacturing Product
Table 79. Samsung Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021) & (US$ Million)
Table 80. Samsung Recent Development
Table 81. Fujifilm Diosynth Biotechnologies Company Details
Table 82. Fujifilm Diosynth Biotechnologies Business Overview
Table 83. Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Product
Table 84. Fujifilm Diosynth Biotechnologies Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021) & (US$ Million)
Table 85. Fujifilm Diosynth Biotechnologies Recent Development
Table 86. Boehringer Ingelheim Company Details
Table 87. Boehringer Ingelheim Business Overview
Table 88. Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Product
Table 89. Boehringer Ingelheim Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021) & (US$ Million)
Table 90. Boehringer Ingelheim Recent Development
Table 91. Patheon Company Details
Table 92. Patheon Business Overview
Table 93. Patheon Biopharmaceutical Contract Manufacturing Product
Table 94. Patheon Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021) & (US$ Million)
Table 95. Patheon Recent Development
Table 96. Rentschler Biotechnologie Company Details
Table 97. Rentschler Biotechnologie Business Overview
Table 98. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Product
Table 99. Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021) & (US$ Million)
Table 100. Rentschler Biotechnologie Recent Development
Table 101. Biomeva Company Details
Table 102. Biomeva Business Overview
Table 103. Biomeva Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021) & (US$ Million)
Table 104. Biomeva Recent Development
Table 105. Probiogen Company Details
Table 106. Probiogen Business Overview
Table 107. Probiogen Biopharmaceutical Contract Manufacturing Product
Table 108. Probiogen Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021) & (US$ Million)
Table 109. Probiogen Recent Development
Table 110. Cytovance Biologics Company Details
Table 111. Cytovance Biologics Business Overview
Table 112. Cytovance Biologics Biopharmaceutical Contract Manufacturing Product
Table 113. Cytovance Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021) & (US$ Million)
Table 114. Cytovance Biologics Recent Development
Table 115. KBI Biopharma Company Details
Table 116. KBI Biopharma Business Overview
Table 117. KBI Biopharma Biopharmaceutical Contract Manufacturing Product
Table 118. KBI Biopharma Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021) & (US$ Million)
Table 119. KBI Biopharma Recent Development
Table 120. WuXi Biologics Company Details
Table 121. WuXi Biologics Business Overview
Table 122. WuXi Biologics Biopharmaceutical Contract Manufacturing Product
Table 123. WuXi Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021) & (US$ Million)
Table 124. WuXi Biologics Recent Development
Table 125. Abzena Company Details
Table 126. Abzena Business Overview
Table 127. Abzena Biopharmaceutical Contract Manufacturing Product
Table 128. Abzena Revenue in Biopharmaceutical Contract Manufacturing Business (2016-2021) & (US$ Million)
Table 129. Abzena Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical Contract Manufacturing Market Share by Type: 2020 VS 2027
Figure 2. Growth Factors Features
Figure 3. Interferons Features
Figure 4. Monoclonal Antibodies Features
Figure 5. Recombinant Hormones Features
Figure 6. Vaccines Features
Figure 7. Insulin Features
Figure 8. Others Features
Figure 9. Global Biopharmaceutical Contract Manufacturing Market Share by Application: 2020 VS 2027
Figure 10. Autoimmune Diseases Case Studies
Figure 11. Oncology Case Studies
Figure 12. Metabolic Diseases Case Studies
Figure 13. Ophthalmology Case Studies
Figure 14. Cardiovascular Diseases Case Studies
Figure 15. Infectious Diseases Case Studies
Figure 16. Neurology Case Studies
Figure 17. Respiratory Disorders Case Studies
Figure 18. Others Case Studies
Figure 19. Biopharmaceutical Contract Manufacturing Report Years Considered
Figure 20. Global Biopharmaceutical Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 21. Global Biopharmaceutical Contract Manufacturing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 22. Global Biopharmaceutical Contract Manufacturing Market Share by Regions: 2020 VS 2027
Figure 23. Global Biopharmaceutical Contract Manufacturing Market Share by Regions (2022-2027)
Figure 24. Global Biopharmaceutical Contract Manufacturing Market Share by Players in 2020
Figure 25. Global Top Biopharmaceutical Contract Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical Contract Manufacturing as of 2020
Figure 26. The Top 10 and 5 Players Market Share by Biopharmaceutical Contract Manufacturing Revenue in 2020
Figure 27. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Type (2016-2021)
Figure 28. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Type (2022-2027)
Figure 29. North America Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. North America Biopharmaceutical Contract Manufacturing Market Share by Type (2016-2027)
Figure 31. North America Biopharmaceutical Contract Manufacturing Market Share by Application (2016-2027)
Figure 32. North America Biopharmaceutical Contract Manufacturing Market Share by Country (2016-2027)
Figure 33. United States Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Canada Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Europe Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Europe Biopharmaceutical Contract Manufacturing Market Share by Type (2016-2027)
Figure 37. Europe Biopharmaceutical Contract Manufacturing Market Share by Application (2016-2027)
Figure 38. Europe Biopharmaceutical Contract Manufacturing Market Share by Country (2016-2027)
Figure 39. Germany Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. France Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. U.K. Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Italy Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Russia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Nordic Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Share by Type (2016-2027)
Figure 47. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Share by Application (2016-2027)
Figure 48. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Share by Region (2016-2027)
Figure 49. China Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Japan Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. South Korea Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Southeast Asia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. India Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Australia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Latin America Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Latin America Biopharmaceutical Contract Manufacturing Market Share by Type (2016-2027)
Figure 57. Latin America Biopharmaceutical Contract Manufacturing Market Share by Application (2016-2027)
Figure 58. Latin America Biopharmaceutical Contract Manufacturing Market Share by Country (2016-2027)
Figure 59. Mexico Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Brazil Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Share by Type (2016-2027)
Figure 63. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Share by Application (2016-2027)
Figure 64. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Share by Country (2016-2027)
Figure 65. Turkey Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 66. Saudi Arabia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 67. UAE Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 68. Lonza Group Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2016-2021)
Figure 69. Baxter Biopharma Solutions Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2016-2021)
Figure 70. Samsung Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2016-2021)
Figure 71. Fujifilm Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2016-2021)
Figure 72. Boehringer Ingelheim Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2016-2021)
Figure 73. Patheon Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2016-2021)
Figure 74. Rentschler Biotechnologie Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2016-2021)
Figure 75. Biomeva Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2016-2021)
Figure 76. Probiogen Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2016-2021)
Figure 77. Cytovance Biologics Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2016-2021)
Figure 78. KBI Biopharma Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2016-2021)
Figure 79. WuXi Biologics Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2016-2021)
Figure 80. Abzena Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2016-2021)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed

Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size, Status and Forecast 2021-2027
QYR2104Z0829 2021年4月 91Pages
QYResearch社発行の本調査資料では、バイオ医薬品受託製造（BCMO）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（哺乳類ベース製造、微生物ベース製造、その他）、用途別市場規模（バイオ医薬品会社、製薬会社、創薬会社、その他）、主要地域別...

世界のバイオ医薬品受託製造（BCMO）市場規模・現状・予測（2021年-2027年）

Global Biopharmaceutical Contract Manufacturing Market Size, Status and Forecast 2021-2027
QYR2104Z0828 2021年4月 90Pages
QYResearch社発行の本調査資料では、バイオ医薬品受託製造（BCMO）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（成長因子、インターフェロン、モノクローナル抗体、組換えホルモン、ワクチン、インスリン、その他）、用途別市場規模（自己免疫...

世界の受託研究機関（CRO）市場規模・現状・予測（2021年-2027年）

Global Contract Research Organization (CRO) Market Size, Status and Forecast 2021-2027
QYR2104Z1571 2021年4月 90Pages
QYResearch社発行の本調査資料では、受託研究機関（CRO）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（前臨床CRO、臨床検査CRO）、用途別市場規模（製薬、バイオテクノロジー、医療機器、その他）、主要地域別市場規模（北米、アメリカ、...

世界の整形外科受託製造市場規模・現状・予測（2021年-2027年）

Global Orthopedic Contract Manufacturing Market Size, Status and Forecast 2021-2027
QYR2104Z4335 2021年4月 90Pages
QYResearch社発行の本調査資料では、整形外科受託製造のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（インプラント、器具、ケース＆トレイ）、用途別市場規模（骨固定、骨置換、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界のパーソナルケア契約製造市場規模・現状・予測（2021年-2027年）

Global Personal Care Contract Manufacturing Market Size, Status and Forecast 2021-2027
QYR2104Z4528 2021年4月 95Pages
QYResearch社発行の本調査資料では、パーソナルケア契約製造のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（天然物、合成物）、用途別市場規模（ヘアケア、スキンケア、メイクアップ＆カラー化粧品、衛生ケア、フレグランス、オーラルケア、その他）...

世界の包装受託製造市場規模・現状・予測（2021年-2027年）

Global Packaging Contract Manufacturing Market Size, Status and Forecast 2021-2027
QYR2104Z4400 2021年4月 96Pages
QYResearch社発行の本調査資料では、包装受託製造のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ブリスター包装、契約包装、食品包装、二次包装）、用途別市場規模（食品＆飲料、消費財、個人医療費、医薬品、その他）、主要地域別市場規模（北米、...

世界の包装受託製造市場規模・現状・予測（2021年-2027年）

世界の製薬契約製造＆契約市場規模・現状・予測（2021年-2027年）

Global Pharmaceutical Contract Manufacturing and Contract Market Size, Status and Forecast 2021-2027
QYR2104Z4562 2021年4月 130Pages
QYResearch社発行の本調査資料では、製薬契約製造＆契約のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射、API、その他）、用途別市場規模（中小企業、大企業）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、...

世界のソフトジェルカプセルにおける医薬品受託製造サービス市場規模・現状・予測（2021年-2027年）

Global Contract Pharmaceutical Manufacturing Services in Softgel Capsule Market Size, Status and Forecast 2021-2027
QYR2104Z1570 2021年4月 99Pages
QYResearch社発行の本調査資料では、ソフトジェルカプセルにおける医薬品受託製造サービスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ゼラチン、非動物）、用途別市場規模（健康補助食品、医薬品、その他）、主要地域別市場規模（北米、アメリカ...

世界のソフトジェルカプセルにおける医薬品受託製造サービス市場規模・現状・予測（2021年-2027年）

世界のバイオ医薬品受託製造（BCMO）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Biopharmaceutical Contract Manufacturing Market The global Biopharmaceutical Contract Manufacturing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analys…
世界のバイオ医薬品受託製造（BCMO）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Biopharmaceutical Contract Manufacturing(BCMO) Market The global Biopharmaceutical Contract Manufacturing(BCMO) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accura…
世界の組換え治療用抗体＆タンパク質市場規模・現状・予測（2021年-2027年） Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…
世界のパーソナルケア契約製造市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Personal Care Contract Manufacturing Market The global Personal Care Contract Manufacturing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and h…
世界の整形外科受託製造市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Orthopedic Contract Manufacturing Market The global Orthopedic Contract Manufacturing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…